IIQ
Click for more information
1.69% 58.0¢ inoviq ltd

Ann: Successful BARD1 Kit Evaluation, page-55

  1. silsol
    3,485 Posts.
    lightbulb Created with Sketch. 295
    clock Created with Sketch.
    10/10/20
    10:22
    Post #: 47994433

    BARD1 CEO, Dr Leearne Hinch, said: “This is an important milestone, enabling us to confidently advance
    the development of a commercial BARD1 autoantibody test for ovarian cancer on the Luminex platform.
    Additionally, the Luminex platform can be applied for development of other tests using our BARD1
    autoantibody approach for breast and lung cancers.    ”
    BD1 Price at posting: 2.6¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GRX GreenX picks up prospective copper project in Germany
right-arrow Created with Sketch.
WGX Westgold sets its sights on top five producer status through merger with Karora
right-arrow Created with Sketch.
SS1 Sun Silver hits silver grades above 200g/t in early-stage portable scanner analysis
right-arrow Created with Sketch.
NEWS Diggers & Dealers 2024: Kim Beazley ties mining and military together; highlights competition with China in Africa
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
NEWS Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
(20min delay)
Last
58.0¢ 		Change
-0.010(1.69%) 		Mkt cap ! $63.96M
Open High Low Value Volume
58.0¢ 58.0¢ 58.0¢ $161 277

Buyers (Bids)

No. Vol. Price($)
2 3106 58.0¢
 

Sellers (Offers)

Price($) Vol. No.
59.0¢ 6499 1
View Market Depth
Last trade - 10.04am 07/08/2024 (20 minute delay) ?
IIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.